Meyka AI API is live for developers.Start building.
Advertisement
Astellas Pharma Inc.

Astellas Pharma Inc. (ALPMF) Stock Overview

Explore Astellas Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

ALPMF●PNK
HealthcareDrug Manufacturers - General
$14.20
$0.20(1.39%)
U.S. Market opens in 50h 40m
Advertisement

Astellas Pharma Inc. (ALPMF)

Meyka AI Score

Z

Key Financials

Market Cap25.4B
P/E Ratio13.94
EPS (TTM)$1.02
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$15.77
3 Months$20.03
1 Year Target$13.72

ALPMF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Astellas Pharma Inc. (ALPMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.94 and a market capitalization of 25.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.39%
5-Day Change
-7.49%
1-Month Change
9.23%
3-Month Change
-12.72%
6-Month Change
16.11%
Year-to-Date (YTD) Change
7.82%
1-Year Change
40.59%
3-Year Change
-11.25%
5-Year Change
-16.27%
All-Time (Max) Change
758447.009%

Contact Information

https://www.astellas.com
81 3 3244 3000
2-5-1, Nihonbashi-Honcho, Tokyo, NaN, 103-8411

Company Facts

14,754 Employees
IPO DateApr 26, 2010
CountryJP
Actively Trading

Frequently Asked Questions